Diagnostics company Quotient Ltd. (QTNT) announced Monday that the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) on Friday for its COVID-19 antibody test. Before granting the EUA, the FDA reviewed not only its COVID-19 antibody test but also the MosaiQ Instrument and related software.
from RTT - Biotech https://ift.tt/3iixKVH
via IFTTT
No comments:
Post a Comment